Lanean...
Low Real-World Eligibility Rates for Nonalcoholic Steatohepatitis Patients for Phase 3 Clinical Trial Criteria Application in a Large Academic Health System
OBJECTIVE: Non-alcoholic steatohepatitis (NASH) is the most common liver disease in the United States. Phase 3 clinical trials have stringent study criteria which may limit real-world generalizability. Thus, we studied whether a real-world, university-based cohort of patients could be eligible for a...
Gorde:
| Argitaratua izan da: | Eur J Gastroenterol Hepatol |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7674230/ https://ncbi.nlm.nih.gov/pubmed/32433419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MEG.0000000000001758 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|